HR c.2582_2583delinsAA ;(p.L861Q)

Variant ID: 8-21978256-GA-TT

NM_005144.4(HR):c.2582_2583delinsAA;(p.L861Q)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma.

Cancers
Hong, Lingzhi L; Lewis, Whitney E WE; Nilsson, Monique M; Patel, Sonia S; Varghese, Susan S; Rivera, Melvin J MJ; Du, Robyn R RR; Chen, Pingjun P; Kemp, Haley N HN; Rinsurongkawong, Waree W; Heeke, Simon S; Spelman, Amy R AR; Elamin, Yasir Y YY; Negrao, Marcelo V MV; Sepesi, Boris B; Gibbons, Don L DL; Lee, J Jack JJ; Wu, Jia J; Vokes, Natalie I NI; Heymach, John V JV; Zhang, Jianjun J; Le, Xiuning X
Publication Date: 2022-07-17

Variant appearance in text: HR: L861Q
PubMed Link: 35884533
Variant Present in the following documents:
  • Main text
  • cancers-14-03473.pdf
View BVdb publication page



Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Osimertinib.

Tuberculosis And Respiratory Diseases
Park, Ji Young JY; Jang, Seung Hun SH; Lee, Chang Youl CY; Kim, Taehee T; Chung, Soo Jie SJ; Lee, Ye Jin YJ; Kim, Hwan Il HI; Kim, Joo-Hee JH; Park, Sunghoon S; Hwang, Yong Il YI; Jung, Ki-Suck KS
Publication Date: 2022-04

Variant appearance in text: HR: L861Q
PubMed Link: 35045686
Variant Present in the following documents:
  • trd-2021-0139.pdf
View BVdb publication page



Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients.

Springerplus
Romero-Ventosa, Elena Yaiza EY; Blanco-Prieto, Sonia S; González-Piñeiro, Ana Lourdes AL; Rodríguez-Berrocal, Francisco Javier FJ; Piñeiro-Corrales, Guadalupe G; Páez de la Cadena, María M
Publication Date: 2015

Variant appearance in text: HR: L861Q
PubMed Link: 25918681
Variant Present in the following documents:
  • 40064_2015_Article_891.pdf
View BVdb publication page



EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

Journal Of Clinical Pathology
Ellison, Gillian G; Zhu, Guanshan G; Moulis, Alexandros A; Dearden, Simon S; Speake, Georgina G; McCormack, Rose R
Publication Date: 2013-02

Variant appearance in text: HR: L861Q
PubMed Link: 23172555
Variant Present in the following documents:
  • jclinpath-2012-201194.pdf
View BVdb publication page